BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38829774)

  • 1. The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks.
    Mansour MSI; Pettersson L; Seidal T; Strömberg U; Mager U; Ali L; Kumbaric S; Hejny K; Taheri-Eilagh F; Mufti J; Nakdali D; Brunnström H
    Cancer Cytopathol; 2024 Jun; ():. PubMed ID: 38829774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer.
    Koomen BM; van der Starre-Gaal J; Vonk JM; von der Thüsen JH; van der Meij JJC; Monkhorst K; Willems SM; Timens W; 't Hart NA
    Cancer Cytopathol; 2021 Apr; 129(4):304-317. PubMed ID: 33108706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CytoLyt fixation significantly inhibits MIB1 immunoreactivity whereas alternative Ki-67 clone 30-9 is not susceptible to the inhibition: Critical diagnostic implications.
    Buonocore DJ; Konno F; Jungbluth AA; Frosina D; Fayad M; Edelweiss M; Lin O; Rekhtman N
    Cancer Cytopathol; 2019 Oct; 127(10):643-649. PubMed ID: 31398281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical Reactivity Comparison between Formalin-Fixed and Liquid-Based Cytology-Fixed Specimens.
    Sakabe N; Maruyama S; Ito C; Shimoyama Y; Komene T; Oboshi W; Sato S; Sudo K; Ikeda K
    Acta Cytol; 2023; 67(1):38-45. PubMed ID: 36228592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry.
    Kawahara A; Taira T; Abe H; Watari K; Murakami Y; Fukumitsu C; Takase Y; Yamaguchi T; Azuma K; Akiba J; Ono M; Kage M
    Cancer Cytopathol; 2014 Feb; 122(2):145-52. PubMed ID: 24167084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
    Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
    Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thyroid transcription factor-1 in malignant pleural effusions.
    Khoor A; Byrd-Gloster AL; Nicosia SV
    Pathol Oncol Res; 2011 Jun; 17(2):263-7. PubMed ID: 20848248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
    Liu L; Cohen C; Siddiqui MT
    Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.
    Carneiro FP; Muniz-Junqueira MI; De Vasconcelos Carneiro M; De Araújo Oliveira Í; Soares AC; De Vargas Haar N; Takano GHS; De Sousa Vianna LM; De Carvalho Caldas G; Vieira DLM; Frutuoso LL; Brito LMR; De Siqueira RVM; Parente AM; De Castro TMML; Peres I; Mendes LMS; Dos Santos Borges TK; Ferreira VM; Motoyama AB
    Oncol Lett; 2019 Aug; 18(2):2019-2024. PubMed ID: 31423273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples.
    Weimholt RC; Sharifai N; Abro B; Vij K; Bernadt C
    J Am Soc Cytopathol; 2019; 8(5):265-269. PubMed ID: 31103372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural effusion cell blocks are reliable resources for PD-L1 analysis in advanced lung adenocarcinomas: a concordance study with matched histologic samples.
    Mahajan S; Nambirajan A; Gupta I; Gupta N; Gupta P; Jain D
    J Am Soc Cytopathol; 2022; 11(5):253-263. PubMed ID: 35589508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
    Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
    Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation.
    Garlin-Politis M; Upadhyay Baskota S; Picon S; Collins N; Virk RK; Cimic A; Yousefi E; Gonzalez A
    J Am Soc Cytopathol; 2024; 13(3):213-218. PubMed ID: 38575468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks.
    Koyi H; Wilander E
    Anticancer Res; 2023 Feb; 43(2):669-673. PubMed ID: 36697096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-4 shows superior specificity for mesothelioma vs non-small-cell lung carcinoma compared with MOC-31 and Ber-EP4.
    Naso JR; Churg A
    Hum Pathol; 2020 Jun; 100():10-14. PubMed ID: 32333920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
    Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
    Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CytoLyt® fixation and decalcification pretreatments alter antigenicity in normal tissues compared with standard formalin fixation.
    Gruchy JR; Barnes PJ; Dakin Haché KA
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):297-302. PubMed ID: 25265430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
    An J; Park S; Sung SH; Cho MS; Kim SC
    Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.